The current status of the hallucinogenic drugs.
D006213:Hallucinogens / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects / Q000627:therapeutic use; D011562:Psilocybin / Q000627:therapeutic use; D019966:Substance-Related Disorders
D006213:Hallucinogens; D011562:Psilocybin; D008238:Lysergic Acid Diethylamide